| Literature DB >> 28767203 |
Britta Kubera1, Claudine Leonhard2, Andreas Rößler2, Achim Peters1.
Abstract
OBJECTIVE: Stress is associated with body mass gain in some people but with body mass loss in others. When the stressor persists, some people adapt with their stress responses, whereas others do not. Heart rate variability (HRV) reflects autonomic variability and is related to stress responses to psychosocial challenges. It was hypothesized that the combined effects of stress exposure and autonomic variability predict long-term changes in body form.Entities:
Mesh:
Year: 2017 PMID: 28767203 PMCID: PMC5573629 DOI: 10.1002/oby.21928
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN: 1930-7381 Impact factor: 5.002
Characterisation of the study population
| Men (n=1369) | Women (n=612) | |||||
|---|---|---|---|---|---|---|
| Phase 5 | Phase 7 | Phase 9 | Phase 5 | Phase 7 | Phase 9 | |
| 55.2±0.2 | 60.8±0.2 | 65.8±0.2 | 55.7±0.2 | 61.1±0.2 | 66.2±0.3 | |
| 80.9±0.3 | 81.6±0.3 | 81.4±0.3 | 70.0±0.5 | 70.1±0.6 | 70.9±0.6 | |
| 176.6±0.2 | 175.5±0.2 | 175.2±0.2 | 162.9±0.2 | 161.7±0.3 | 161.4±0.3 | |
| 25.9±0.1 | 26.5±0.1 | 26.5±0.1 | 26.4±0.2 | 27.0±0.2 | 27.2±0.2 | |
| 91.9±0.3 | 94.0±0.3 | 95.2±0.3 | 80.8±0.5 | 83.5±0.5 | 85.8±0.5 | |
| 0.521±0.002 | 0.536±0.002 | 0.544±0.002 | 0.49±0.0 | 0.52±0.0 | 0.53±0.0 | |
| 99.6±0.2 | 99.9±0.2 | 100.9±0.2 | 101.3±0.4 | 102.3±0.4 | 104.1±0.4 | |
| 0.564±0.001 | 0.570±0.001 | 0.576±0.001 | 0.62±0.0 | 0.63±0.0 | 0.65±0.0 | |
| 0.922±0.0 | 0.939±0.0 | 0.941±0.0 | 0.80±0.0 | 0.82±0.0 | 0.82±0.0 | |
| 2.7±0.1 | - | - | 4.0±0.3 | - | - | |
| 38.2±0.5 | - | - | 36.3±0.6 | - | - | |
Values are expressed as mean±SEM
assessed by GHQ-30
Heart rate variability [SD of all intervals between R waves with normal-to-normal conduction].
P<0.001; main effect time, ANOVA for repeated measures
Figure 1Phenotypic plasticity of body form in men (left panel) and women (right panel)
In the current paper we used the term ‘lean phenotype’ for people with a BMI <25 kg/m2 and a waist-to-hip ratio (whr) <0.9 (men) or <0.85 (women), the term ‘corpulent phenotype’ for people with a BMI ≥25 kg/m2, the term ‘narrow-waisted phenotype’ for people with a whr <0.9(men) or <0.85 (women) and the term ‘wide-waisted phenotype’ for people with a whr ≥0.9 (men) or ≥0.85 (women). Illustrations are created by a ‘body visualizer’ program available at http://bodyvisualizer.com/male.html. (MPI IS Perceiving Systems Department; Max Planck Gesellschaft)
Figure 2Panel A: High psychological distress and low HRV were associated with increases in body mass in men (n= 1369). General linear model with age as a covariate; test of intra-subject effects: F=4.0; P=0.007; *significant differences were found for group 2 vs. 3 P=0.014
Panel B: High psychological distress and low HRV were associated with increases in hip-to-height ratio in men (n=1369). General linear model with age as a covariate; test of intra-subject effects: F=4.4; P=0.004; *significant differences were found for group 2 vs. 3 with P=0.021
Panel C: Changes in waist-to-height ratio over time in dependence of autonomic variability and psychological distress in men (n=1369). General linear model with age as a covariate; test of intra-subject effects: F=2.7; P=0.046.
Figure 3Panel A: Changes in body mass over time in dependence of autonomic variability and psychological distress in women (n= 603). General linear model with age and having periods as covariates; test of intra-subject effects: F=2.3; P=0.073; trend for differences between group 1 vs. 3 P=0.061
Panel B: Changes in hip-to-height ratio over time in dependence of autonomic variability and psychological distress in women (n=603). General linear model with age and having periods as covariates; test of intra-subject effects: F=2.4; P=0.063; trend for differences between group 1 vs. 3 P=0.089
Panel C: Changes in waist-to-height ratio over time in dependence of autonomic variability and psychological distress in women (n=603). General linear model with age and having periods as covariates; test of intra-subject effects: F=2.6; P=0.053; trend for differences between group 1 vs. 3 P=0.063
Note a reduced number of cases due to missing values for the covariate “having periods”
Body mass index over time in 1369 men
ANOVA for repeated measures with BMI at phases 5, 7 and 9 as dependent variable; age, HRV at phase 5, and psychological distress (GHQ-30) at phase 5 as independent variables.
| Dependent variable BMI at phases 5, 7, 9 | Inner-subject effects |
|---|---|
| F=16.8; P=0.001 | |
| F= 8.1; P=0.001 | |
| F= 6.3; P=0.003 | |
| F= 4.8; P=0.011 |
All covariates (n=59) were tested regarding their impact on BMI over time (supplemental table 2). The following covariates showed a significant impact on BMI over time (supplemental table 2): age, life satisfaction, MET mild exercise, sleep duration, alcohol dependence, cigarette smoking, rheumatic arthritis drugs, general health index, any longstanding illness, incident diabetes, hypertension. These covariates were considered in the analyses 1-2.
The inner-subject effect ‘time × psychological distress’ remained significant after separate adjustment for the following covariates: age (see table 2), life satisfaction (F=3.8; P=0.029), MET mild exercise (F=5.8; P=0.004), sleep duration (F=5.0; P=0.005), alcohol dependence (F=5.6; P=0.005), cigarette smoking (F=6.0; P=0.004), rheumatic arthritis drugs (F=5.8; P=0.005), general health index (F=4.3; P=0.018), any longstanding illness (F=5.2; P=0.008), incident diabetes (F=6.7; P=0.002), hypertension (F=5.4; P=0.007)
The inner-subject effect ‘time × HRV’ remained significant after separate adjustment for the following covariates: age (see table 2), life satisfaction (F=5.0; P=0.010), MET mild exercise (F=4.6; P=0.013), sleep duration (F=4.9; P=0.010), alcohol dependence (F=4.2; P=0.019), cigarette smoking (F=4.3; P=0.018), rheumatic arthritis drugs (F=4.2; P=0.019), general health index (F=4.3; P=0.017), any longstanding illness (F=4.8; P=0.011), incident diabetes (F=5.4; P=0.006), hypertension (F=3.9; P=0.026).
Hip-to height and waist-to-height ratios over time in 1369 men
ANOVA for repeated measures with hip-to-height or weight-to-height ratio at phases 5, 7 and 9 as dependent variable; age, HRV at phase 5, and psychological distress (GHQ-30) as independent variables.
| Dependent variable | Inner-subject effects | Dependent variable | Inner-subject effects |
|---|---|---|---|
| F=1.0; P=0.367 | time | F=7.3; P=0.001 | |
| F=5.6; P=0.004 | time × age | F=0.5; P=0.608 | |
| F=4.3; P=0.016 | time × psychological distress at phase 5 | F=3.4; P=0.038 | |
| F=5.0; P=0.008 | time × HRV at phase 5 | F=1.8; P=0.174 |
All covariates (n=59) were tested regarding their impact on hip-to-height ratio over time (supplemental table 3). The following covariates showed a significant impact on hip-to-height ratio over time (supplemental table 3): relatives with alcoholism, relatives with schizophrenia, marital status, income, employment summary, MET mild exercise, cigarette smoking categorical, anti-hypertensive drugs, CVD medication, ACE inhibitors, anxiolytics, diuretics, nitrate medicine, rheumatic arthritis drugs, general health index, any longstanding illness, hypertension. These covariates were considered in the analyses 1-2.
The inner-subject effect ‘time × psychological distress’ remained significant after separate adjustment for the following covariates: relatives with alcoholism (F=4.3; P=0.015), relatives with schizophrenia (F=3.5; P=0.033), marital status (F=5.6; P=0.005), employment summary (F=4.3; P=0.015), MET mild exercise (F=3.9; P=0.023), cigarette smoking categorical (F=4.1; P=0.020), anti-hypertensive drugs (F=3.8; P=0.024), CVD medication (F=3.6; P=0.029), ACE inhibitors (F=4.0; P=0.021), anxiolytics (F=4.1; P=0.018), diuretics (F=4.2; P=0.017), nitrate medicine (F=3.9; P=0.023), rheumatic arthritis drugs (F=4.0; P=0.022), any longstanding illness (F=3.5; P=0.034), hypertension (F=3.7; P=0.027).
The inner-subject effect ‘time × HRV’ remained significant after separate adjustment for the following covariates: relatives with alcoholism (F=4.9; P=0.009), relatives with schizophrenia (F=5.1; P=0.007), marital status (F=4.9; P=0.008), income (F=3.9; P=0.023), employment summary (F=4.8; P=0.010), MET mild exercise (F=4.4; P=0.014), cigarette smoking categorical (F=4.5; P=0.012), anti-hypertensive drugs (F=4.1; P=0.019), CVD medication (F=3.9; P=0.022), ACE inhibitors (F=4.4; P=0.014), anxiolytics (F=4.6; P=0.012), diuretics (F=4.4; P=0.014), nitrate medicine (F=4.6; P=0.011), rheumatic arthritis drugs (F=4.6; P=0.011), general health index (F=4.7; P=0.011), any longstanding illness (F=5.0; P=0.008), hypertension (F=4.2; P=0.017).
All covariates (n=59) were tested regarding their impact on waist-to-height ratio over time (supplemental table 4). The following covariates showed a significant impact on waist-to-height ratio over time (supplemental table 4): parents unemployed, MET mild exercise, cigarette smoking, ACE inhibitors, incident diabetes, and hypertension. These covariates were considered in analysis 3.
The inner-subject effect ‘time × psychological distress’ remained significant after separate adjustment for the following covariates: parents unemployed (F=4.0; P=0.020), cigarette smoking (F=3.3; P=0.040), incident diabetes (F=3.7; P=0.027).